deltatrials
Completed PHASE3 INTERVENTIONAL 1-arm NCT01266902

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

An Open-label Trial With TMC278 25 mg q.d. in Combination With a Background Regimen Containing 2 N(t)RTI's in HIV-1 Infected Subjects Who Participated in TMC278 Clinical Trials and Were Still Benefitting From Treatment With TMC278

Sponsor: Janssen R&D Ireland

Conditions HIV-1 Infection
Interventions Rilpivirine
Updated 26 times since 2017 Last updated: Feb 10, 2021 Started: Feb 28, 2011 Primary completion: Feb 29, 2020 Completion: Feb 29, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01266902, this PHASE3 trial focuses on HIV-1 Infection and remains completed. Sponsored by Janssen R&D Ireland, it has been updated 26 times since 2011, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshot~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshot~Jul 2017 – ~Sep 2017 · 2 months · monthly snapshot~Sep 2017 – ~Feb 2018 · 5 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Nov 2019 · 6 months · monthly snapshot~Nov 2019 – ~Jan 2020 · 2 months · monthly snapshot~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Dec 2021 · 8 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

26 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Apr 2021 — Dec 2021 [monthly]

    Completed PHASE3

▶ Show 21 earlier versions

  1. Jan 2021 — Apr 2021 [monthly]

    Completed PHASE3

  2. May 2020 — Jan 2021 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  3. Apr 2020 — May 2020 [monthly]

    Active Not Recruiting PHASE3

  4. Mar 2020 — Apr 2020 [monthly]

    Active Not Recruiting PHASE3

  5. Jan 2020 — Mar 2020 [monthly]

    Active Not Recruiting PHASE3

  6. Nov 2019 — Jan 2020 [monthly]

    Active Not Recruiting PHASE3

  7. May 2019 — Nov 2019 [monthly]

    Active Not Recruiting PHASE3

  8. Apr 2019 — May 2019 [monthly]

    Active Not Recruiting PHASE3

  9. Mar 2019 — Apr 2019 [monthly]

    Active Not Recruiting PHASE3

  10. Jan 2019 — Mar 2019 [monthly]

    Active Not Recruiting PHASE3

  11. Dec 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE3

  12. Nov 2018 — Dec 2018 [monthly]

    Active Not Recruiting PHASE3

  13. Sep 2018 — Nov 2018 [monthly]

    Active Not Recruiting PHASE3

  14. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting PHASE3

  15. Feb 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

  16. Sep 2017 — Feb 2018 [monthly]

    Active Not Recruiting PHASE3

  17. Jul 2017 — Sep 2017 [monthly]

    Active Not Recruiting PHASE3

  18. Jun 2017 — Jul 2017 [monthly]

    Active Not Recruiting PHASE3

  19. Apr 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE3

  20. Feb 2017 — Apr 2017 [monthly]

    Active Not Recruiting PHASE3

  21. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Janssen R&D Ireland
Data source: Janssen R&D Ireland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Alicante, Spain , Antwerp, Belgium , Austin, United States , Bangkok, Thailand , Barcelona, Spain , Beijing, China , Berlin, Germany , Beverly Hills, United States , Bloemfontein, South Africa and 87 more locations